Bionano Genomics Q2 Revenue USD 8.2 Million
BNGO•Other Q2 Metrics
- Q2 gross margin: 53%
- Q2 adjusted operating expenses: USD 8.7 million
Q2 Revenue and Operating Expenses
Aug. 10 (Reuters) - Bionano Genomics Q2 revenue was USD 8.2 million. Q2 operating expenses were USD 11.5 million.
Related News
Community West Bancshares Q2 FY26 net income drops 65.59% to $2.7 million; net interest margin widens 26 basis points to 4.56%
CWBC•
Wingstop director Jay A. Snowden files initial beneficial ownership statement
WING•
